SSc-PAH incidence has not been shown to be predicted using baseline BNP or NT-proBNP levels, but these markers have been useful in monitoring the severity of disease with elevated levels being associated with higher risk of mortality [39]. The gene discussed is NPPB; the disease is pulmonary arterial hypertension.